These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 30013325)

  • 1. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials.
    Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z
    Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials.
    Wang Y; Cai X; Fang Q; Zhu J
    J Neurol Sci; 2024 Mar; 458():122912. PubMed ID: 38325064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration.
    Warach SJ; Ranta A; Kim J; Song SS; Wallace A; Beharry J; Gibson D; Cadilhac DA; Bladin CF; Kleinig TJ; Harvey J; Palanikumar L; Doss VT; Marescalco R; Fink JN; Tyson A; Schlick KH; Noh L; Wilson D; Figueroa S; Pech MA; Paletz LB; Lewis MK; Castro M; Sahlein DH; Lafranchise EF; Sandall J; Asif KS; Geraghty SR; Cullis PA; Malisch T; Neill TA; LaMonte MP; Campbell BCV; Wu TY
    JAMA Neurol; 2023 Jul; 80(7):732-738. PubMed ID: 37252708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study.
    Teivane A; Jurjāns K; Vētra J; Grigorjeva J; Kupcs K; Masiliūnas R; Miglāne E
    Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143846
    [No Abstract]   [Full Text] [Related]  

  • 5. Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Ahmed S; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2018 Nov; 46(4):440-450. PubMed ID: 30117036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.
    Wei H; Fu B; Yang C; Huang M
    Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.
    Huang X; MacIsaac R; Thompson JL; Levin B; Buchsbaum R; Haley EC; Levi C; Campbell B; Bladin C; Parsons M; Muir KW
    Int J Stroke; 2016 Jul; 11(5):534-43. PubMed ID: 27048693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tenecteplase in comparison to alteplase in acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Salamatullah HK; Bashrahil B; Alghamdi AM; Alsharm FS; Alkulli OA; Alzahrani Z; Alkhiri A; Alghamdi S; Makkawi S
    Clin Neurol Neurosurg; 2023 Oct; 233():107961. PubMed ID: 37713743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis.
    Thelengana A; Radhakrishnan DM; Prasad M; Kumar A; Prasad K
    Acta Neurol Belg; 2019 Sep; 119(3):359-367. PubMed ID: 29728903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocol.
    Bivard A; Garcia-Esperon C; Churilov L; Spratt N; Russell M; Campbell BC; Choi P; Kleinig T; Ma H; Markus H; Molina C; Hsu C; Tsai CH; Meretoja A; Strbian D; Butcher K; Wu T; Davis S; Donnan G; Levi C; Parsons M
    Int J Stroke; 2023 Jul; 18(6):751-756. PubMed ID: 36655938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenecteplase vs. alteplase for the treatment of patients with acute ischemic stroke: a systematic review and meta-analysis.
    Ma P; Zhang Y; Chang L; Li X; Diao Y; Chang H; Hui L
    J Neurol; 2022 Oct; 269(10):5262-5271. PubMed ID: 35776193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Rose D; Cavalier A; Kam W; Cantrell S; Lusk J; Schrag M; Yaghi S; Stretz C; de Havenon A; Saldanha IJ; Wu TY; Ranta A; Barber PA; Marriott E; Feng W; Kosinski AS; Laskowitz D; Poli S; Mac Grory B
    Stroke; 2023 May; 54(5):1192-1204. PubMed ID: 36951049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenecteplase versus alteplase for patients with acute ischemic stroke: a meta-analysis of randomized controlled trials.
    Zhang X; Wan TF; Chen J; Liu L
    Aging (Albany NY); 2023 Dec; 15(24):14889-14899. PubMed ID: 38149983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials.
    Abuelazm M; Seri AR; Awad AK; Ahmad U; Mahmoud A; Albazee E; Kambalapalli S; Abdelazeem B
    J Thromb Thrombolysis; 2023 Feb; 55(2):322-338. PubMed ID: 36449231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
    Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
    Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials.
    Huang J; Zheng H; Zhu X; Zhang K; Ping X
    Ann Med; 2024 Dec; 56(1):2320285. PubMed ID: 38442293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Term Efficacy Outcomes of Tenecteplase versus Alteplase for Acute Ischemic Stroke: A Meta-Analysis of 5 Randomized Trials.
    Requiao LE; Oliveira RS; Reis LS; B Assis AP; G Moreno BN; Cordeiro LR; Solla DF
    Neurol India; 2022; 70(4):1454-1459. PubMed ID: 36076643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions: Systematic Review and Meta-Analysis.
    Katsanos AH; Safouris A; Sarraj A; Magoufis G; Leker RR; Khatri P; Cordonnier C; Leys D; Shoamanesh A; Ahmed N; Alexandrov AV; Tsivgoulis G
    Stroke; 2021 Jan; 52(1):308-312. PubMed ID: 33272127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of tenecteplase and alteplase in acute ischemic stroke: A pairwise and network meta-analysis of randomized controlled trials.
    Rehman AU; Mohsin A; Cheema HA; Zahid A; Ebaad Ur Rehman M; Ameer MZ; Ayyan M; Ehsan M; Shahid A; Aemaz Ur Rehman M; Shah J; Khawaja A
    J Neurol Sci; 2023 Feb; 445():120537. PubMed ID: 36630803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.